Glunicate

This classification denotes an anti-lipidemic agent with the molecular formula C36H28N6O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C62ZH19B0L, chemically known as 2-deoxy-2-nicotinamido-beta-d-glucopyranose 1,3,4,6-tetranicotinate but generally known as glunicate, which bears US NIH Compound Identifier 71243. European Medicines Agency schedules Glunicate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07942MIG. The term GLUNICATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). GLUNICATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule glunicate under HS 29349990 and SITC 51579. As of Q4 2014, GLUNICATE remains the US FDA Preferred Term for this commodity. Glunicate bears US NLM identifiers UMLS ID C0061453 and NCI Concept Code C87632. SMILES: O1C(C(OC(=O)c2cccnc2)C(OC(=O)c2cccnc2)C(NC(=O)c2cccnc2)C1OC(=O)c1cccnc1)COC(=O)c1cccnc1.